OBJECTIVES -To investigate long-term mortality and its temporal trends as of 1 January 1999 among the 1,075 patients with type 1 diabetes (onset age Ͻ18 years, diagnosed between 1965 and 1979) who comprise the Allegheny County population-based registry.
T
he introduction of insulin into clinical use in the 1920s dramatically changed the life of children with type 1 diabetes. Before that time, onset of the disease meant almost certain death. Results from the Joslin Clinic showed that 10-year survival of patients diagnosed as having diabetes in the 1930s was higher than 90% (1) . More recently, a follow-up study from the Children's Hospital of Pittsburgh reported that the mortality of subjects diagnosed between 1950 and 1981 was seven times higher than that of the general population as of 1982 (2) . The study also showed that the 10-year mortality decreased from 4.1 to 1.4% during this period. However, these results do not necessarily represent the mortality of the total diabetic population, because the study was hospital-based.
The Diabetes Epidemiology Research International (DERI) group conducted an international study comparing the mortality (as of 1 January 1990) of patients diagnosed between 1965 and 1979 in population-based registries from four countries: U.S. (Allegheny County, PA), Finland, Japan, and Israel. The mortality in Allegheny County was five times higher than that of the general population (3) (4) (5) . European reports of population-based studies from Norway (6) and the U.K. (7, 8) suggest that the mortality of children with type 1 diabetes was two to three times higher than that of the general population. The report from the U.K. also noted that the standardized mortality ratios (SMRs) decreased from 981 to 238 during the period 1940 -1989 (8) . However, very limited information is available in the U.S. regarding time trends in mortality with duration of diabetes of Ͼ10 years for patients diagnosed in recent years (9) . This is particularly important because medical care improved greatly with the advent of self-monitoring blood glucose (10), HbA 1c (11) , and angiotensin-converting enzyme inhibitor use (12) in recent years. Therefore, the current study assessed the long-term mortality and temporal trends in prognosis for the subjects diagnosed between 1965 and 1979 with follow-up of at least 19 years. Differences in ethnic group (AfricanAmerican versus Caucasian) and sex were also examined.
RESEARCH DESIGN AND
METHODS -Subjects were identified from the type 1 diabetes incidence registry in Allegheny County, PA, which was developed through periodic review of hospital records and validated by contact with pediatricians in the community (13) . This is the same cohort as studies in earlier DERI reports (3-5) and has been fully described previously (3) (4) (5) 13) with the degree of ascertainment estimated to be Ͼ95% (13) . Inclusion criteria were a diagnosis of diabetes before 18 years of age between 1 January 1965 and 31 December 1979, residence in Allegheny County, PA, at onset, and administration of insulin beginning at the time of diagnosis. Persons were excluded if they had developed
From the 1 Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania; the diabetes from a secondary cause, i.e., diabetes associated with cystic fibrosis or Down's syndrome and steroid-induced diabetes. As of 1 January 1980, 1,075 eligible cases were identified from the Allegheny County registry.
Initially, permission was obtained from the hospital of diagnosis to contact the attending or referring physician for each eligible case. Upon approval, permission was then obtained from the attending/referring physician to contact their patients by letter and then phone for the initial follow-up (conducted in 1985). To ascertain the living status of cases as of 1 January 1999, contact was again made first by letter with a questionnaire and a consent form. If the subjects did not respond to this questionnaire, they were contacted by phone. If the whereabouts of subjects were not confirmed by these procedures, tracking through the Social Security Death Index (www.ancestry.com) and the National Death Index was also used (14) . These procedures were approved by the Institutional Review Board of the University of Pittsburgh.
Analysis
Overall, sex-and race-specific mortality rates per person-year of follow-up were determined. To assess the temporal trends of mortality, the total cohort was divided into three groups by year of diagnosis (1965-1969, 1970 -1974, and 1975-1979) . Temporal trends were also assessed by race and sex. The 2 test for trend was used to assess the trends of mortality. Life-table analyses by the Kaplan-Meier method were performed. Log-rank test was used to determine the statistical difference between the survival curves both overall and by sex, race, and diagnosis cohort. Although performed, the more detailed analyses (e.g., by diagnosis cohort within race) are limited by small sample size. The SMRs were calculated considering dynamic calendar date and age with reference to the National Vital Statistics Report (15). Person-years were partitioned by decade and age, sex, race, and calendar year. Similar specific background mortality rates covering the same period were used for calculation of SMRs. To investigate the effects of sex, age at diagnosis, race, and year at diagnosis (1965-1969, 1970 -1974, and 1975-1979) , Cox proportional hazard model was used. The 95% CIs were determined based on the Poisson distribution (16) . Statistical analyses were conducted with SAS software (17) .
RESULTS -As of 1 January 1999, the living status of 972 of the 1,075 total cases was confirmed (90.4%). There were no statistical differences between the traced and missing cases in age at onset (mean ϩ SD 10.6 ϩ 4.0 vs. 10.7 ϩ 3.7 years, respectively; mean year at onset 1971 ϩ 4.1 vs. 1972.1 ϩ 4.0, respectively) and sex (51.6 vs. 55.7% male, respectively). However, African-Americans were less likely to be traced than Caucasians (93.3% of Caucasians were traced vs. 86.8% of African-Americans). The demographic details by race and sex are listed in Table 1 . Age at onset for the subjects diagnosed between 1975 and 1979 was significantly higher than those diagnosed in 1965-1969 and 1970 -1974 (P ϭ 0.01). Overall, 170 deaths were observed (17.5%) ( Table 2 ). The mean duration of diabetes of the cases at death or censoring was 25.2 Ϯ 5.8 (SD) years. Overall, the mortality rate was 627 per 100,000 person-years (95% CI 532-728). Sex, race, and temporal morbidity data are shown in Table 2 . The mortality of African-Americans was significantly higher that that of the Caucasians (P Ͻ 0.05); however, the difference was less marked when race-specific SMRs were compared. The mortality rate in women tended to be higher than in men; the SMR for women (1,041) was substantially higher than for men (325).
At 20-year duration of diabetes (Table  2) , a significant improvement in mortality by diagnosis cohort was seen (P Ͻ 0.01). However, no difference in mortality was noted by either sex or race at 20 years duration of diabetes.
Life-table analyses of the total cohort by the Kaplan-Meier method indicated that the cumulative survival was 98% at 10 years, 92.1% at 20 years, and 79.6% at 30 years (Fig. 1A) . Little difference was seen by sex (Fig. 1B) , although the survival curve of African-Americans (Fig.  1C) was significantly worse than that of Caucasians, especially after 25-year duration of diabetes (P Ͻ 0.0001). The survival rate of the 1975-1979 cohort (Fig.  1D ) was significantly higher than that of the 1965-1969 cohort (P ϭ 0.03). Between 10 and 20 years duration of diabetes, 8.4% of the subjects died in the earliest cohort (1965) (1966) (1967) (1968) (1969) , whereas only 3.5% of the subjects died in the latest cohort (1975) (1976) (1977) (1978) (1979) (Fig. 1D) . The analyses of temporal trend of mortality showed a declining trend for both Caucasians and African-Americans; however, this was not significant in either race. In African-Americans, Ͼ20% of the subjects died at 20 years duration of diabetes in the oldest cohort (1965) (1966) (1967) (1968) (1969) ; however, only 11% of the subjects died at 20 years duration of diabetes in latest cohort (1975) (1976) (1977) (1978) (1979) . In the oldest cohort, more than half of the African-Americans had died at the 30 years duration of diabetes ( Fig. 1E and F The reasons for a higher mortality in the U.S. may relate to the costly health care system for diabetes (5); the high financial burden may keep patients from frequent contact with physicians. In Finland and Norway, where mortality was reported to be lower, free medical care is provided for type 1 diabetes. Greater contact with a diabetes specialist care team has also been suggested to be related to a reduced risk of death in Pittsburgh (18) . Another component of the higher mortality in the U.S. is the higher mortality of African-Americans, which has previously been reported as a twofold excess mortality in the same cohort (19) . The difference in prognosis after 20 years duration of diabetes was evident. However, because the mortality in the general population is also higher in African-Americans, the SMRs for diabetes are relatively similar in both African-Americans and Caucasians. Thus, the poorer prognosis for African-Americans with type 1 diabetes reflects an underlying general ethnic disparity rather than a diabetes-specific entity. No difference in the mortality rates by sex was apparent in the current analysis, which is consistent with a previous report (20) . However, the SMR for women was significantly higher than that of men, reflecting the lower background mortality in women.
Several studies have examined temporal trends in mortality associated with type 1 diabetes. In a study from Denmark, based on 2,930 type 1 diabetic patients diagnosed before the age of 31 years between 1933 and 1972, the relative mortality of type 1 diabetes decreased as calendar years at diagnosis increased after 1950 during this period (21) . The study from the U.K., based on 845 patients diagnosed between 1940 and 1989, reported a major decline in mortality and SMRs by decade of diagnoses, especially between the 1940s and the 1950s. However, there were no clear differences in survival curves by decade of diagnosis between 1950 and 1980. A mortality study from Cuba showed that no improvement was observed in mortality of the cases diagnosed between 1965 and 1980 (22) .
In the present study, mortality, especially after 15 years duration of diabetes, 95% CIs according to the Poisson distribution are given in the parentheses. Mortality rate of African-Americans is significantly higher than that of Caucasians (P Ͻ 0.05). At 20 years duration of diabetes, the time trend in mortality rates was significant (P ϭ 0.01).
has declined during the last 30 years. The decline was most evident for the cases diagnosed in 1975-1979 compared with 1965-1969 . SMRs at 20-year duration of diabetes showed a decreasing tendency (Table 2) over the study period, indicating that the improving prognosis of diabetic children was greater than that of the general population. In this report, the prognosis of African-Americans is much worse than that of Caucasians after 25 years of diabetes. However, the decline in mortality seemed to be similar in both Caucasians and African-Americans. The present study suggests that the improvement of mortality up to 15 years duration of diabetes of type 1 diabetes patients may have reached a plateau. Further cause-specific analyses are needed to determine whether any further improvement in the first 15-year duration is possible.
One limitation of the current study is that the living status of 10% of cases was not determined. This partially reflects the lack of residence registration in the U.S. and the fact that the Social Security numbers of the patients were not recordable when the registry was started. This would be particularly helpful for tracing women who married after initial registration and who are very difficult to locate after they have changed their surnames. However, because we have used the National Death Index for the duration between 1980 and 1998, it is likely that we have identified most of the deceased patients in the cohort as long as the patients died in the U.S. Therefore, it is likely that our results are not biased and that the mortality rates presented here may be a little overestimated; the denominator may be proportionally higher because the missing patients are likely to be alive.
In conclusion, this study shows that the long-term mortality of children with type 1 diabetes has been improving in re- cent years, reflecting, in all probability, the better glycemic control and blood pressure treatment available since the early 1980s. Encouraging improvements are seen in African-Americans, as well as Caucasians, although survival continues to be worse in African-Americans. Continued follow-up and cause-specific analyses of death will, hopefully, help to further document and explain improvement in mortality and suggest strategies to reduce mortality to background level.
